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Research over the past three decades has shown that the mammalian immune system can be
altered by the occupational exposure of asbestos. Early clinical studies generally focused on
systemic observations of immune alteration such as the number and function of peripheral
lymphocytes and monocytes. More recently as the regulatory influence of local immunity in health
and disease becomes more defined, immunologic changes occurring in the lung, the primary target
organ of asbestos, have been significant areas of investigation. This review will focus on recent
studies that examine the influence of asbestos on pulmonary immunity as well as the role of host
immune competence in asbestos-related disease. - Environ Health Perspect 106(Suppl 1):
159-169 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/159-169rosenthal/abstract.html
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Introduction
Occupational exposure to asbestos is widely
believed to pose an increased risk for a
range ofpulmonary diseases and is consid-
ered an important cause of pulmonary
cancer (i.e., diffuse malignant mesothe-
lioma, bronchiogenic carcinoma). The pre-
dominant disease associated with asbestos
exposure, asbestosis, is characterized by an
interstitial pulmonary fibrosis commonly
thought to represent the terminal phase of
chronic inflammation (1,2). This inflam-
matory response, along with evidence of
peripheral immune changes following
asbestos exposure, has long implicated the
pathogenesis ofasbestos-related disease (3).
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Unlike many industrial immunotoxi-
cants, for which relatively little clinical data
are available, there exists a comparatively
large literature database documenting the
direct and indirect effects of asbestos on
the human immune system, although the
specific role of these changes in eliciting
asbestos-related disease is unclear. In numer-
ous clinical studies both humoral and cellu-
lar immunity have been targets ofasbestos
toxicity (4-12). For example, studies per-
formed in the late 1980s by researchers at
the Mount Sinai School ofMedicine, New
York (4) used peripheral blood lymphocytes
in their examination ofT cells, T-cell sub-
sets, and natural killer (NK) cells in 118
healthy control subjects and compared these
data to those obtained from 20 patients
with clinically diagnosed malignant meso-
thelioma and 375 long-term asbestos work-
ers without neoplasia. These studies showed
that whereas the absolute numbers oftotal
T cells and T-helper (Th) cells were normal
in asbestos workers without neoplasia, these
cells were significantly reduced in patients
with neoplasia. T-suppressor (Ts) cells, on
the other hand, remained unchanged in the
mesothelioma population but were signifi-
cantly elevated among the asbestos workers
without neoplasia. This imbalance in T-cell
subsets resulted in a marked reduction in
Th to Ts ratios in mesothelioma patients
and in asbestos workers.
Similar to its effects on cellular
immunity, a number of reports demon-
strate asbestos-associated changes in
humoral immunity, as manifested by
increased circulating levels ofimmunoglob-
ulins (6), including auto-antibodies and
rheumatoid factors (8,10-12). More
recently, studies have experimentally
demonstrated the importance of certain
components of the complement system
(13,14) and the importance offiber depo-
sition and interstitial translocation to the
ultimate pathology associated with
asbestos-related inflammation. Specifically,
following transepithelial passage, fiber-
induced activation of local complement
can generate potent chemoattractants that
likely serve as important initiators of
inflammatory events (13,14). These studies
were recently reviewed by Warheit and
Hesterberg (15). The purpose ofthis paper
is to summarize recent key developments
in our understanding of the complex
interactions of asbestos with cells of the
immune system.
Influence ofAsbestosExposure
onNonspecific Inmmunity:
Natural KillerCells
Natural killer cells are a unique lymphocyte
population with the ability to rapidly
lyse tumor cells independent ofmajor his-
tocompatibility complex gene products
(16) and are thought to be the first line
of defense against cancer cells or virally
infected cells (17,18).
In addition to the ability ofasbestos
fibers to substantially increase the riskofpul-
monary malignancy, clinical studies have
shown that NKcells isolated from peripheral
blood of patients with asbestosis have
impaired NK cell activity, thus leading to
speculation that such suppression mayhave a
causative or multiplicative effect on the risk
forlungcancer in these individuals (4,5). To
date, it is not known ifthis immune deficit
precedes or is the consequence ofneoplastic
and/or fibrotic development or if the
immunologic perturbations are an epiphe-
nomena unrelated to the pathogenesis of
asbestos-induced cancer.
Considering the established role ofNK
cells in tumor immunosurveillance, an ade-
quate understanding of asbestos-induced
suppression ofNK cell activity may pro-
vide insight into the mechanism(s) by
which asbestos exerts its carcinogenicity.
Unfortunately the early clinical assessments
ofperipheral lymphocytes provide only an
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indirect indication of the immunologic
status ofthe host lung, as pulmonary tissue
itselfpossesses an effective localized system
of immunologic components, including
the alveolar macrophage (AM) and intersti-
tial lymphocytes. Thus, while circulating
NK cells may play a role in controlling the
development of pulmonary cancer, the
interstitial pulmonary NK cell is a more
likely candidate for the local control of
neoplastic development in the lung.
Within the interstitial pulmonary lympho-
cyte population, lung NK cells exist in
great quantity, with an effective percentage
exceeding that of any other organ of the
body on a per-lymphocyte basis (19), a
characteristic that may have evolved in
response to the numerous carcinogenic
challenges of inspired air. Although the
specific role of these cells in asbestos-
induced lung disease remains unknown, a
reasonable hypothesis maintains that these
lung-localized cells protect the host from
altered phenotype expression(s) that may
arise during the pathogenesis ofasbestosis.
In support of this role, recent studies have
shown the ability of NK cells to lyse
tumors ofmesothelial origin (20).
In light of the previously reported
observations ofdecreased number and func-
tion ofcirculating NK cells in asbestos-
exposed workers, studies were conducted to
examine the influence ofinhaled asbestos on
interstitial NK number and function in
C57BL/6 mice (21). In these studies
C57BL/6 mice were exposed to chrysotile
asbestos (-13.3 mg/m3) for 3 hr/day for 3
days and animals sacrificed at 7, 28, and 56
days postexposure. Functional assessment of
the interstitial NK population was deter-
mined by evaluation oftheir ability to lyse
target YAC-1 cells. As in Table 1, the ability
ofpulmonary NK cells to lyse target cells
was significantly suppressed in asbestos-
exposed mice on days 7 and 56 postexposure
compared to air-exposed animals. Although
cytotoxicity appears decreased in asbestos-
exposed animals on day 28, the degree of
suppression did not reach statistical signifi-
cance. This suppression in target cell-medi-
ated cytotoxicity by NK cells isolated from
asbestos-exposed mice correlated to some
extent with the percentages of NK cells
recovered from these mice, which were
below those recovered from air controls at all
time points examined (Table 2). The effect
ofasbestos on pulmonary NK cells appears
relatively specific, as the relative and absolute
numbers ofpulmonary T cells (Table 2) and
splenic NK cells (data not shown) were
generally unaffected at these times.
It is often difficult to sort out the
causative forces occurring soon after asbestos
exposure because of inflammation-related
cell trafficking. Thus, time points taken
long after exposure are often useful in sort-
ing out effects that may or may not be
related to the presence and activity of
inflammatory cells. Asbestos inhalation in
this study, as in others, was immediately fol-
lowed by a marked neutrophil accumulation
that had not resolved at the first measured
time point, day 7 postexposure (Table 3).
However, this dynamically changing cell
population appeared to normalize 28 days
postexposure and is therefore unlikely to
account for the observation ofsuppressed
NK cell numbers (via dilution) on days 28
and 56 or the impaired functional activity
on day 56. Thus, it appears that in addition
to the decreased levels of circulating NK
cells previously reported in humans (4,5),
the number oflocal or interstitial NK cells
in pulmonary tissue may also be altered
following exposure to asbestos. Further
studies will be necessary to understand the
importance ofthis altered cellular distribu-
tion in local immune regulation as well as in
the pathogenesis ofasbestos-related disease.
Table 1. Effect of asbestos inhalation on interstitial
natural killer cell-mediated cytotoxicity.
Group Days postexposure Cytotoxicity, %
Air 7 22±5
Asbestosa 7 9 ± 3*
Air 28 18±6
Asbestosa 28 13 ± 4
Air 56 19±2
Asbestosa 56 10 ± 3*
"Whole-body asbestos exposure to C57BL/6 mice for 3
hr/day for 3 consecutive days at a concentration of
-13.3 mg/m3. Each value represents the mean ± SD of
6 to 12 mice per group. *Significantly different
(p<0.05) from corresponding air control groups using
Student's t-test.
Influence ofAsbestos
onNonspecificImmunity:
LungMacrophages
Pulmonary macrophages seem to play a
central role in asbestos-induced chronic
inflammation and fibrosis in the lung (22).
Anatomically, this heterogeneous group of
cells can be distinguished by their pul-
monary distribution, i.e., airway, alveolar,
interstitial, intravascular, and pleural. These
specific cells have different morphologic
features and most likely exhibit different
responses on interactions with particulates
(23). AM represent the first line ofdefense
in the alveolar region ofthe lung and their
expansion in the lung is a typical character-
istic ofasbestos exposure in both humans
and experimental animals. For example,
increased numbers of activated AM have
been found in the lower respiratory tract
of humans chronically exposed to high
concentrations of asbestos fibers (24).
Inhalation ofasbestos by rats demonstrated
a 10-fold increase in the number ofAM
and a 3-fold increase in interstitial
macrophages in the lung 2 days after
asbestos exposure (22). Total macrophage
numbers in the lung may increase by a
Table 2. Effect of asbestos inhalation on interstitial
natural killer cells and interstitial Tcells.
Group
Air
Asbestosa
Air
Asbestosa
Air
Asbestos'
Days
postexposure
7
7
28
28
56
56
NK 1.1
19.4± 4.1
7.0 ± 0.6*
22.7 ± 2.0
13.9 ± 2.9*
22.7 ± 1.8
17.3 ± 1.3*
Thy 1.2
52.1 ± 10.6
46.4 ± 8.4
50.3 ± 3.6
57.6 ± 5.4
56.4 ± 5.3
52.3 ± 5.0
aWhole-body asbestos exposure to C57BL/6 mice for 3
hr/dayfor3 consecutive days at a concentration of-13.3
mg/m3. Each value represents the mean ± SD of 6 to 12
mice per group. *Significantly different (p<0.051 from
corresponding air control groups using Student's t-test.
Table 3. Differential analysis of nylon wool-purified interstitial pulmonary cells in asbestos- and air-exposed mice.
Recovered cells, %
Group Days postexposure Lymphocytes Neutrophils Macrophages
Air 7 86±3 12±5 3±2
Asbestosa 7 68± 4* 29± 5* 4± 1
Air 28 89±6 10±5 1±1
Asbestosa 28 90 ±4 8 4 2 1
Air 56 87±2 7±3 5±4
Asbestosa 56 87 ±2 10 3 4 1
8Whole-body asbestos exposure to C57BL/6 mice for 3 hr/day for 3 consecutive days at a concentration of -13.3
mg/m3. Each value represents the mean ± SD of 6 to 12 mice per group. *Significantly different(p<0.05) from cor-
responding air control groups using Student's t-test. Note: nylon wool would be expected to remove the majority
of macrophages.
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variety ofmechanisms including migration
of blood monocytes, local proliferation of
the AM (25,26), or asbestos-induced gen-
eration of chemotaxins such as certain
complement components (13,14). The
role of the other locally produced factors
such as monocyte chemotactic protein 1
(MCP-1) and macrophage inflammatory
protein (MIP)-1a and -1i, known chemo-
attractants for monocytes (27), is not yet
well characterized for the asbestos-induced
inflammatory response. In addition, the
proliferative response of the AM popula-
tion seen after silica and asbestos exposure
may be induced by colony-stimulating fac-
tors (28) and is believed to be associated
with the formation ofmultinucleated giant
cells (29), a prominent feature in the chronic
stage ofasbestosis and silicosis (30,31). In
addition, AM produce insulinlike growth
factor (IGF)-1 and express its receptor, thus
creating an environment for the autocrine
stimulation ofAM proliferation (32,33).
AM provide dual defense ofthe lower
respiratory tract, induding phagocytosis and
removal ofinhaled fibers and triggering local
immunologic events that may be protective.
As a phagocytic cell the AM helps clear the
lung ofinhaled particles. Evaluation ofAM
from humans and animals exposed to high
concentrations ofasbestos show phagocy-
tized fibers in numerous AM (24). Several
lines of in vitro evidence suggest that AM,
unlike the polymorphonudear neutrophil(s)
(PMN), which also increase in asbestosis,
can reduce asbestos-induced epithelial cell
injury through initiation of key repair
processes (34,35).
Activated AM are abundant sources of
proinflammatory mediators and growth fac-
tors with important roles in the pathogenesis
ofinflammatory and fibrotic processes in the
lung. The oxygen meta-bolites and
eicosanoids released from AM during the
phagocytosis ofasbestos fibers are well docu-
mented (24,36,37). Overwhelming evidence
shows that the pulmonary macrophage can
be stimulated by asbestos to express and
secrete multiple inflammatory cytokines,
chemokines, and growth factors participat-
ing in both auto-crine and paracrine stimula-
tion ofresident lung cells and blood cells
(Table 4). Tumor necrosis factor (TNF)
alpha has received considerable attention in
this regard, as several lines ofevidence sug-
gest that it plays a significant role in fiber-
induced lung disease. AM secrete TNF-a
after in vivo inhalation, in vitro exposure to
asbestos fibers (38-40), and AM from
asbestosis patients (41) or patients with his-
tory of chronic asbestos exposure (38)
demonstrate an increase in TNF-a message
expression and secretion. Additionally,
excess TNF-a correlates with development
of fibrosis in animal models ofasbestosis
(42,43). Interestingly, the long fibers,
which are generally considered more car-
cinogenic and fibrogenic than short fibers
of similar diameter (44), stimulated a
greater release ofTNF-a than the short
samples (45). TNF-a administrated in
vivocan elicit manyofthe responses associ-
ated with asbestosis, including proliferation
offibroblasts (46,47), stimulation ofextra-
cellular matrix proteins (41), and elicita-
tion of inflammatory cells via enhanced
adhesion molecule expression and the pro-
duction of chemokines (48). Consistent
with a role for TNF in particulate-related
lung disease, studies have shown that the
administration of antibodies to TNF-a
prevents collagen deposition induced by
silica, another fibrogenic material (49).
In light of their propensity to elicit
potent inflammatory cytokines, it is not sur-
prising that AM are thought to be involved
in the recruitment ofneutrophils to the
lung. AM from subjects with asbestosis
release neutrophil chemotactic factors (50),
which may be a secondary response to
TNF-a and directly stimulated by asbestos
itself. The presence ofneutrophils is a fre-
quent finding in animal models ofasbestosis
(22) and humans occupationally exposed to
asbestos (51,52). Elevated neutrophils are
often associated with lung damage, as they
are potent producers ofreactive oxygen and
proteolytic enzymes, both with the potential
to destroy respiratory tissue. Human inter-
leukin (IL)-8 and its mouse analog MIP-2,
chemokines from the a-intecrine family, are
the most stable and potent chemotactic fac-
tors for PMN in the lung (53). Further evi-
dence for fiber-induced induction of
inflammatory cytokines can be seen in
recent studies showing that silica induces
MIP-2 from AM (54) and asbestos stimu-
lates IL-8 production from lung epithelial
cells (55) and human AM (56).
Table 4. Asbestos-induced cytokines and growth fac-
tors produced by pulmonary macrophages.
Cytokines/growth factors Reference
TNF-oa (35,38,40-42,120)
IL-1a/IL-l (39,120,137)
IL-6 (139)
TGF-a (63)
PDGF (58)
IGF (32)
Fibroblast growth factor (138)
There is now substantial evidence that
the pulmonary macrophage may be involved
in tissue remodeling in the lung. AM from
individuals with asbestos exposure sponta-
neously release large amounts offibronectin
(24), a potent chemoattractant for lung
fibroblasts (57). Additionally, asbestos-
induced secretion ofplatelet-derived growth
factor (PDGF) (58), a potent mitogen and
chemoattractant for mesenchymal cells (59),
has been described for AM as well as many
other cells in the lung; the mechanisms of
the expression ofPDGF isoforms have been
studied extensively (60,61). Studies on the
activation ofinterstitial macrophages have
revealed that they release fibroblast growth
factors, including PDGF, which maybe par-
ticularly important in light oftheir proxim-
ity to the target interstitial fibroblast (62).
Asbestos-stimulated pulmonarymacrophages
are also a source ofadditional fibroblast
growth factors such as IGF-1 (32) and trans-
forming growth factor alpha (TGF-a) (63),
a growth factor with potent mesenchymal
and epithelial mitogenic activity expressed in
the lung at sites of asbestos deposition
(64,65). It is likely that this growing list of
growth-promoting factors is influential in
both asbestos-induced fibrosis as well as in
theepithelial repairprocesses in thelung.
InfluenceofAsbestos Exposure
onNonspecificImmunity:
Epithelial Cells
Recently, pulmonary parenchymal cells have
been recognized as participants in normal
immune regulation as well as in various
pulmonary disease states. For example, in
addition to PDGF, pulmonary fibroblasts
secrete MIP-la (66), a peptide with leuko-
cyte-activating and chemotactic properties,
as well as IL-8, a potent chemoattractant
(67). Similarly, pulmonary epithelial cells
can produce IL-8 and MCP-1 (68).
Considering that intactalveolarspace is lined
by epithelial cells, direct asbestos-epithelial
cell contact without intervening AM is
likely to occur. Type II epithelial cells alone
account for over 15% ofthe cells in the dis-
tal lung (69) and their direct proximity to
inspired air make their functional properties
an integral consideration in understanding
the pathophysiology ofasbestos-induced
lung disease. Furthermore, pulmonary neu-
trophils, a consistent finding in asbestos-
exposed workers (52,53), correlate with the
duration ofasbestos exposure (52). They
have been strongly implicated in the
pathogenesis of asbestos-induced fibrosis
through release of reactive oxygen inter-
mediates and proteases (70,71), with
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resulting tissue damage. Prompted by
these observations, our laboratory at the
National Institute ofEnvironmental Health
Sciences (Research Triangle Park, NC) ini-
tiated studies to assess the direct effects of
asbestos fibers on chemokine secretion in
pulmonary epithelial cells.
In these studies the human pulmonary
type II epithelial cell line A549 cultured in
the presence ofeither chrysotile or crocido-
lite asbestos induced a dose-dependent
increase in IL-8 release (Figure 1, Table 5).
Ofthe two fibers crocidolite was slightly
more potent than chrysotile, resulting in a
20-fold increase in IL-8 secretion when com-
pared with untreated cells. The chemotactic
activity for human neutrophils was also
examined to establish whether immunoreac-
tive IL-8 detected in culture supernatants
was biologically active. As in Figure 2, cul-
ture supernatants from asbestos-exposed
A549 cells induced a marked chemotactic
response that was inhibitable by >60% after
incubation with anti-IL-8 antibody, demon-
strating that mostofthis chemotactic activity
is likely to be bioactive IL-8. Wollastonite
and titanium oxide, poorlyfibrogenic agents,
did not elicit IL-8 when tested at signifi-
cantly higher concentrations than used for
asbestos (Figure 3), suggesting that specific
physicochemical properties ofthe fibers play
a key role in this response. Factors such as
fiber size, surface charge, charge density, sur-
face adsorption, reactive surface sites, and
chemical composition have all been sug-
gested as contributors to asbestos-associated
biologicactivity (72).
The membrane signaling events
responsible for IL-8 production in pul-
monary epithelial cells possess some speci-
ficity, with IL-1 and TNF inducing large
amounts and lipopolysaccharide showing
little or no stimulatory capacity (67). The
role ofmembrane signaling events requir-
ing actin-myosin filament assembly such
as phagocytosis (73) was also examined,
specifically comparing IL-8 release stimu-
lated byTNF and asbestos. In these studies
cytochalasin D, an inhibitor ofmicrofila-
ment assembly, did not influence TNF-
mediated IL-8 release but substantially
inhibited asbestos-mediated IL-8 release.
This finding suggests that in contrast to
proinflammatory cytokine-mediated signal-
ing, asbestos-mediated signaling requires
the assembly ofactin-myosin filaments.
These data suggest that epithelial cells
in addition to macrophages and fibroblasts
may be important effector cells in the
immunopathogenesis ofasbestos-associated
diseases and in particular in the neutrophilic
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Figure 1. Il-8 release from A549 cells after addition of
(A) chrysotile or (B) crocidolite asbestos. A549 cells
were plated at 3x105/well in 24-well microtiter plates
and incubated overnight to achieve confluence.
Eighteen hours after plating, culture media was
decanted and replaced with 1 ml fresh media. Asbestos
fibers were suspended in F12 media with serum and
added to cultures in 20-pI aliquots. Cells were incu-
bated for an additional 18 hr and IL-8 present in cul-
tures was quantitated using a commercially available
enzyme-linked immunosorbent assay (ELISA) system.
*p<0.05. Data adapted from Rosenthal et al. (55).
infiltration that is frequently observed
following asbestos exposure. Nevertheless, it
is important to remember that pulmonary
epithelial cells do not exist singularly and
the production ofTNF and IL-1 by other
lung cells such as the AM can influence
cytokine production from epithelial cells.
The relative importance of these varying
sources has yet to be defined.
The Influence ofAsbestos
on Specific Immunity
One of the most consistent findings in
individuals chronically exposed to asbestos
is an elevation in serum immunoglobulins
(IgA, IgG, IgM, IgE) and mucosal (salivary)
IgA and the presence of autoantibodies
(antinuclear antibody, rheumatoid factor)
(7,8,9). The incidence ofautoantibodies in
asbestos-exposed workers with radiographic
abnormalities varies widely and ranges
from 3 to 28% for antinuclear antibody
and from 10 to 38% for rheumatoid factor
(7,8,10,12,74). Although elevated levels
of IgG and IgM appear to correlate with
chest radiographic classification ofpneu-
moconiosis, no correlation exists between
Table 5. Lactate dehydrogenase release.
Asbestos, pg/cm2 U/liter
Chrysotile
0 16.1 ±0.7
2.49 17.9±0.3
4.98 19.0±2.2
9.95 22.1 ± 1.4
19.9 26.6± 1.1
Total release 132.1 ±4.5
Crocidolite
0 17.2±0.5
2.49 19.9± 1.4
4.98 22.1 ± 1.9
9.95 28.5± 1.6
19.9 39.7±0.4
Total release 132.1 ±4.5
LDH, lactate dehydrogenase release. LDH was used as
a measure of cellular damage. Values are expressed as
mean ± SD of quadruplicate cultures. Data adapted
from Rosenthal et al. (55).
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Figure 2. Supernatants from A549 cells previously
stimulated for 18 hrwith 6.0 pg/mI crocidolite asbestos
± 30 min incubation with 1:100 dilution of polyclonal
anti-IL-8 antiserum. A mean of 302 neutrophils/high-
powered field was observed with the positive control
(10-7 M formyl-met-len-phe). Values are representative
of duplicate experiments. Data adapted from Rosenthal
et al. (55).
autoantibody production or serum immuno-
complexes and the severity ofasbestosis (9).
Regardless of its correlation with disease
state, the presence ofautoantibodies, ele-
vated serum immunoglobulins, and the
detection ofserum immunocomplexes are
indicative ofB-lymphocyte hyperactivity in
asbestos-exposed workers. In vitro studies
using human cell lines have shown that
both chrysotile and crocidolite asbestos can
complex with immature B lymphocytes
and stimulate cellular proliferation (75),
and in vivo studies in experimental animals
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Figure 3. Effects of nonfibrogenic dusts on the release
of IL-8 from A549 cells. Wollastonite and titanium oxide
were added at a concentration of 80 pg/mI and [l-8
quantitated using a commercially available ELISA sys-
tem. Values are expressed as mean ± SD of quadrupli-
cate cultures. Data adapted from Rosenthal etal. (55).
injected with crystalline asbestos have
shown a boost in serum y-globulin levels
(8). Furthermore, an adjuvantlike effect of
asbestos in rodents has been demonstrated
and appears related to an AM membrane
surface-related structure (76). Such an
asbestos-related neoantigen may play a part
in nonorgan-specific autoantibodies in
some patients with asbestosis. Asbestos
exposure is associated with an increase in Ia
expression, a mediator ofmacrophage-lym-
phocyte communication on the surface of
AMs, which may induce these cells to stim-
ulate self-targeting lymphocytes (77).
Alternatively, it has been suggested that
asbestos-induced B-cell overactivity may be
related to decreased suppressor cell activity
and/or numbers previously reported in
asbestos-exposed workers.
Although the effects of asbestos on
humoral immunity can be considered
hyperactive, the clinical studies to date por-
tray a significantly depressed cell-mediated
immune response in asbestos-exposed indi-
viduals. A clear relationship between defec-
tive T-cell functions and the fibrotic
response in asbestosis has been demon-
strated (7,78,79), with the intensity ofthe
decrease paralleling the severity of the dis-
ease (79). Asbestos-exposed patients with
impaired T-cell responses have more severe
fibrotic abnormalities (as determined by
chest radiography) than those with normal
responses, and patients with increases in
bronchoalveolar lymphocytes present with
less physiologic impairment than those
with increased neutrophils and eosinophils
(78,80-82). Furthermore, the unexpected
longevity of a patient with malignant
pleural mesothelioma was associated with
normal lymphocyte surface markers and
functions in contrast to mesothelioma
patients who terminally progressed with
suppressed numbers and function ofT and
B lymphocytes (83). However, in one study
no association was found between impaired
cellular immunity and asbestos-associated
malignancy in eight of ten patients with
asbestos-associated pleural mesothelioma
and without lung fibrosis (78), indicating
that impaired T-cell function is an unlikely
finding in all asbestos-associated malig-
nancy. In patients with radiographic evi-
dence ofparenchymal asbestosis, both the
relative and absolute number ofcirculating
T lymphocytes were significantly depressed
compared to control (7). This T-cell deficit
was associated with suppressed mitogen-
induced lymphocyte proliferation, cuta-
neous anergy to dinitrochlorobenzene, and
depressed delayed-type hypersensitivity to
several antigens (7,84-86). In vitro studies
with human peripheral blood lymphocytes
have shown that asbestos-depressed phyto-
hemoagglutinin A induced lymphoprolifer-
ation in a manner that was only partially
related to cytotoxicity (87,88). Reduced
CD4:CD8 ratios in bronchoalveolar lavage
fluid have been described in asbestos-
exposed workers with and without radio-
logic evidence of asbestosis; this finding
has correlated with pleural thickening
(89-91). Alocal excess ofTs cells or deple-
tion ofTh cells might result from nonspe-
cific activation of the immune system
secondary to AM activation by asbestos.
Although unlikely, reduced CD4:CD8
ratios may result from nonspecific direct
damage to lymphocytes by asbestos fibers.
It is conceivable that the loss ofTs cell reg-
ulation could explain the B-cell reactivity
and that the neoplastic cell-transforming
properties ofasbestos might act in concert
with this immune-deficient host. In addi-
tion one may speculate that the previously
described effects on NK cells may be
related to the observation that among
asbestos-exposed workers with depressed
T-cell functions there is an increase in the
number of the effector Ts (Leu2+ Leu8-)
subsets that regulate both the Th:Ts ratio
as well as B- and NK cell activity (92).
Although T cells are clearly a target of
asbestos exposure, it is important to note
that asbestos-exposed individuals present
myriad patterns ofT-cell subset alterations,
including an increased CD4:CD8 ratio
(93). Interestingly, chrysotile asbestos
interferes with phytohemaglutin or con-
canavalin A-induced release of fibroblast
inhibitory growth factor (FIGF) from
peripheral blood lymphocytes in vitro
(94). Thus, while FIGF may regulate
the extent of connective tissue prolifera-
tion during normal repair process, suppres-
sion of it by asbestos may contribute to
excessive fibroblast accumulation and
subsequent fibrosis.
Although most immunologic alter-
ations are generally found in patients with
radiologic evidence of asbestosis, two
studies have reported leukopenia in pre-
sumably healthy individuals with occupa-
tional asbestos exposure (95,96). Thus, it
is difficult to establish whether the cellular
defects precede or are the consequences of
the development offibrosis. To answer this
question, our laboratory evaluated asbestos-
induced inflammatoryand fibrotic responses
in lungs ofimmunodeficient mice (Balb/c
nu/nu) and severe combined immunodefi-
cient (SCID) (C3H) mice, immunologi-
cally normal mice of the same genetic
background, and immunodeficient mice
reconstituted with syngeneic T lympho-
cytes (97). In these studies, increases
in bronchoalveolar lavage cell numbers
occurred in asbestos-treated immunodefi-
cient mice compared to asbestos-treated
immunocompetent mice or immuno-
deficient mice that were reconstituted
with crude and purified T lymphocytes
(Table 6). Differential analysis ofthe col-
lected cells portrayed a predominantly neu-
trophilic infiltrate, which correlated with
increased levels ofLTB4 and PGE2. Both
asbestos-treated athymic and SCID mice
showed a significant increase in total lung
Table 6. Effect of chrysotile asbestos on total cells and cell differential in pulmonary lavage fluid 6 weeks after
exposure in immunocompetent, SCID, or reconstituted SCID mice.
Strain/treatment Total cells, x 105 Macrophages, % Neutrophils, %
C3H/air 0.93 ± 0.10 89.5 ± 1.6 9.4± 1.2
C3H/asbestos 1.93 ± 0.08' 83.9 ± 5.2 9.6 ± 3.6
SCID/air 1.28 ± 0.17 94.6 ± 0.9 4.6 ± 0.6
SCID/asbestos 5.61 ± 1.43' 60.6 ± 2.0 37.8 ± 1.8#
SCID-L/asbestos 1.72 ± 0.121* 88.0 ± 3.4* 10.4 ± 3.0*
SCID-T/asbestos 1.76 ± 0.20* 91.6 ± 2.6* 7.2 ± 2.2*
Each value represents the mean ± SE of three to seven determinations. Statistical analysis was performed using
the Student's t-test. p<0.05 compared to asbestos-exposed SCID mice. *p<0.5 versus asbestos-exposed SCID
mice. SCID-L are SCID mice reconstituted with 2x 107 unfractionated lymphocytes; SCID-T are SCID mice reconsti-
tuted with 1 x107 purified T lymphocytes. SCID mice were of C3H genetic background. Table adapted from Corsini
et al. (97).
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hydroxyproline when compared to asbestos-
treated immunocompetent mice (Table 7).
Consistent with this, lung hydroxypro-
line was reduced in asbestos-exposed
SCID mice reconstituted with T lympho-
cytes and conversely increased in T-cell
depleted Balb/c mice (data not shown).
Histopathologic assessment demonstrated
that asbestos exposure was associated with
both cellular and fibrogenic inflammatory
responses, with asbestos-exposed SCID
mice presentingwith a more severe cellular
response than similarly exposed normal
mice (Table 8). Taken together, these data
indicate that T cells influence asbestos-
induced lung damage by minimizing both
the inflammatory and fibrotic responses
and taken together are consistentwith a pro-
tective role for T lymphocytes in asbestosis.
It is likely that the more severe neutrophil
infiltration and the greater retention time of
these cells in the lung ofimmunodeficient
mice causes more extensive lung injury.
Table 7. Effect of chrysotile asbestos on total lung
hydroxyproline 6weeks postexposure.
Strain/treatment Hydroxyproline, mg/lung
C3H/air 224.2 ± 6.2
C3H/asbestos 280.8 ± 15.7#
SCID/air 235 ± 6.6
SCID/asbestos 482.9 ±22.5'
SCID-L/asbestos 387.8 ± 19.9#*
SCID-T/asbestos 413.5 ±38.68
Each value represents the mean ± SE ofthree to seven
determinations. Statistical analysis was performed
using the Student's t-test. Op<0.05 compared to air-
exposed C3H or air-exposed SCID mice. *p<0.05 sig-
nificantly different versus asbestos-exposed SCID
mice. Table adapted from Corsini etal. (97).
Table 8. Histologic evaluation of normal C3H, SCID,
and reconstituted SCID mice 6 weeks after asbestos
exposure: incidence and severity ofpulmonary lesions.
Strain/treatment lncidencea Severityb
C3H/air 0/8 -
C3H/asbestos 4/9 1.0
SCID/air 0/10 -
SCID/asbestos 8/8 2.1
SCID-L/asbestos 10/10 1.2
SCID-T/asbestos 8/8 1.2
&Number of mice affected/number evaluated. hSeverity
of collagen deposition was based on evaluation of a
single Trichrome-stained section from each animal. All
slides were evaluated initially to determine the maxi-
mal extent of the lesion then reevaluated and semi-
quantitatively graded on a scale of +1 (minimal) to +3
(maximal). This grading was based on the number of
inflammatory foci in the section that contained
increased collagen, as well as the amount of collagen
present in individual foci. Combined experiments are
shown. Table adapted from Corsini etal. (97).
Based on these experimental studies and
the above described human observations,
solid evidence supports the notion that
impaired cell-mediated immunity may rep-
resent a predisposing factor in asbestos-
induced fibrosis. Further studies are
necessary to determine the specific T-cell
mediators that are critical to the regulation
ofasbestos-induced diseases.
The Role of Iron and Reactive
Oxygen Species in Asbestos
Immunotoxicology
A number of studies have shown that
asbestos-induced pathophysiologic responses
are associated with generation ofvarious
reactive oxygen species (ROS) such as
superoxide anions (O2), hydrogen perox-
ide (H202), and hydroxyl radicals (OH).
Asbestos may initiate the formation ofsuch
species through two principal mechanisms:
via iron-catalyzed reactions such as the
Haber-Weiss reaction or by activation of
the respiratory burst activity inherent to
phagocytic cells (98). The fiber itselfis rich
with physical and chemical properties that
alone can initiate substantial reactivity with
its surrounding environment. Asbestos
fibers are composed ofnumerous hydrated
silicates rich in negative charges, with a
large capacity to complex transition metals
on their surface (99,100). Iron is the basic
transition metal on the fiber surface and is
present at concentrations proportional to
the density of acidic functional groups
(101,102). Iron catalyzes the generation of
high ROS from H202 and O2- through
Fenton and Haber-Weiss reactions
(103,104). Production ofhighly reactive
hydroxyl radicals by asbestos fibers has
been shown in cell-free chemical systems
(105,106) as well as in lungs of animals
exposed to asbestos via intratracheal instal-
lation (107). As asbestos fibers can easily
penetrate cells (1) they can introduce iron
into the cytosol and trigger the generation
ofhydroxyl radicals in the vicinity ofkey
membrane or intracellular molecules.
Studies demonstrated recently that asbestos
may complex intracellular iron sources
and this additional iron may increase the
reactive lifetime of the fibers (108,109).
In this respect asbestos bodies removed
from human lung at autopsy have con-
tained on their surface redox-active iron
capable of catalyzing DNA single-strand
breaks (110).
An additional mechanism for the induc-
tion of oxidative stress by asbestos is
through the activation ofmacrophages and
polymorphonuclear leukocytes to release
ROS in the form ofH202 and 02- (111).
In iron-catalyzed reactions these metabo-
lites can be converted to hydroxyl radicals.
Incomplete internalization oflong asbestos
fibers, so-called frustrated phagocytosis
(112), or the specific stimulation of oxi-
dant-producing enzymes such as reduced
nicotinamide adenine dinucleotide phos-
phate oxidase (113) may together account
for the increase in oxygen metabolites
released from phagocytic cells following
asbestos exposure. Oxygen free radical pro-
duction may not be restricted only to
phagocytic cells because epithelial cells,
widelyavailable to inhaled fibers at the alve-
olar surface, are also capable of releasing
oxygen species (114).
Asbestos-initiated oxidative reactions
can effect vital cellular macromolecules
such as DNA, lipids, and proteins, leading
to cell and nuclear damage, lipid peroxida-
tion, and other events associated with cell
death (108,115-117). Oxidative stress may
not be terminally destructive but in moder-
ate levels can initiate the synthesis ofpro-
teins associated with cellular physiologic or
pathophysiologic responses. For example,
ROS modulate events in the signal trans-
duction cascade through an effect on pro-
tein phosphorylation (118,119). Recent
studies have shown a link between
asbestos-induced oxidative stress and acti-
vation of regulatory proteins involved in
asbestos-mediated diseases in the lung, sug-
gesting the existence ofa cytokine network
as an obligatory part ofasbestos fiber-cell
interactions. TNF-a released from AM is
likely a key mediator in this process. Iron-
catalyzed oxidative radicals have been
involved in asbestos-induced signaling of
TNF-a expression and secretion (120). A
number of studies evaluating the role
of iron and the production of ROS in
asbestos toxicity utilize the potent iron
chelator desferrioxamine. For example,
treatment ofasbestos fibers with desferriox-
amine effectively chelates ferric ions from
the fiber surface, decreases the ability of
asbestos to generate OH radicals (100),
and decreases the ability to induce cell toxi-
city (121), lipid peroxidation (122,123),
and DNA damage (124). Pretreatment of
asbestos fibers with desferrioxamine or
treatment ofAM with asbestos in the
presence of desferrioxamine markedly
diminishes the ability of the fibers to
stimulate TNF-a production (Figure 4).
Similar inhibition ofan asbestos-induced
TNF-ct response was demonstrated by
membrane-permeable hydroxyl scavengers
such as dimethylthiourea (DMTU),
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Figure 4. Effect of desferrioxamine on asbestos-induced TNF-x release by rat alveolar macrophages. AM were
cultured with desferrioxamine and crocidolite asbestos (50 pg/mI). Results are presented as the percentage of the
TNF response to asbestos alone. Values represent mean ± SE; n = 4 experiments. Data adapted from Simeonova
and Luster(120). *p<0.05.
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Figure 5. Inhibition of asbestos-induced IL-8 pro-
moter-driven transcription by antioxidants. A549 cells
were transfected with 1.5 pg IL-8 Chloramphenicol
acetyltransferase (CAT) reporter plasmid and 0.5 mg
of ,B-actin luciferase control plasmid. The transfected
cells were cultured with medium alone; asbestos (12.5
pg/mI); asbestos in the presence of 10 mM TMTU or
DMTU, orTMTU or DMTU alone. The activation of IL-8
promoter was determined by assaying the CAT con-
centration of cellular extracts prepared 26 to 28 hr
after transfection. Transfection efficiencies were nor-
malized by analyzing luciferase activity. The results
are presented relative to CAT levels in unstimulated
cells. Experiments were repeated a total of three
times with representative data shown. Data adapted
from Simeonova and Luster (125).
tetramethylthiourea (TMTU), and dimethyl
sulfoxide. Additionally, TNF-ax secretion
from AM is stimulated by H202 or glu-
cose-glucose oxidase, generating H202; this
response is increased in the presence of
ferrous sulfate, which catalyzes hydroxyl
radical generation through Fenton reaction.
Asbestos-induced oxidative stress is also
involved in the stimulation ofcytokine
responses from pulmonary epithelial cells
(125,126). Membrane-permeable hydroxyl
scavengers significantly attenuate asbestos-
activated IL-8 and IL-6 gene expression in
pulmonary epithelial cells. Free radical gen-
erating systems induce IL-8 and IL-6 secre-
tion similar to asbestos. Using antioxidants,
transient transfection assays using an IL-8
promoter construct linked to a Chloram-
phenicol acetyltransferase reporter gene
revealed that asbestos-mediated redox-oxida-
tive intracellular changes are involved in the
IL-8 promoter activation (Figure 5).
Cytokine gene transcription and
expression are generally associated with the
modulation ofgene promoter regions by
sequence-specific binding of proteins,
referred to as transcription factors. Nuclear
factor (NF)-KB is a transcription factor
controlling the gene expression ofmany
inflammatory cytokines including TNF-a,
IL-la, IL-8, and IL-6 (127-129). There is
increasing evidence that the redox-oxidative
stage ofthe cell can play a role in NF-cKB
activation (130,131). ROS may serve in the
posttranslational modification ofNF-iKB
complex induding the phosphorylation and
proteolysis ofthe inhibitory protein IkB,
resulting in release ofactive DNA binding
complex (132). Asbestos causes hamster
tracheal epithelial cells to generate nuclear
proteins that bind to the NF-iKB consensus
DNA sequences. Preexposure of cells
with N-acetyl-L-cysteine, a precursor of
the antioxidant glutathione, ameliorates
DNA-binding activity (133). Furthermore,
asbestos fibers activate nudear protein bind-
ingto the binding sites ofspecific inflamma-
tory cytokine genes, specifically stimulating
nuclear protein binding to the NF-wB and
NF-IL-6 cognate regulatory elements
located in the promoter regions ofIL-6 and
IL-8 (125,126). For maximal expression of
many inflammatory mediators, NF-iKB
binding occurs simultaneously with NF-IL-
6 transcription factor (134-136). Nuclear
protein binding to both NF-icB and NF-IL-
6 binding sites is diminished by TMTU, an
intracellular hydroxyl scavenger. Thus,
asbestos-induced changes in intracellular
oxidative-redox state appear to activate both
NF-iKB and NF-IL-6 binding, which coor-
dinately may regulate IL-8 or IL-6 expres-
sion in lung epithelial cells. Thus, asbestos
fibers, by the presence ofiron on their sur-
face, may induce generation ofoxidizing
species that modulate the intracellular
redox-oxidative state, which contributes to
activation of transcription factors such as
NF-KB and NF-IL-6 and the subsequent
stimulation ofinflammatory cytokines.
Conclusion
Asbestos has proven to be an important
immunotoxicant with effects on both sys-
temic and local immunity. In fact few, if
any, immunologic cells appear to be spared
by asbestos exposure, either through direct
effects or as a result ofthe hosts' protective
response to exposure. Although recent
studies have begun to shed light on the
cellular and subcellular events responsible
for asbestos-related immune dysfunction,
these same studies have also shown the
remarkable complexity in fiber-cell and
cell-cell interactions involved in asbestos-
related disease processes. However, key
questions remain to be fully understood,
including an understanding ofthe genetic
predisposition of individuals with a ten-
dency for immunologic hyperactivity to
asbestos, the interactions between sys-
temic and local immune changes, and
the influence of complex mixtures of
cytokines/growth factors on the patho-
genesis ofasbestos-induced lung disease
Nevertheless, the impressive data generated
to date on asbestos-immune system interac-
tions will likely aid in identifying the toxic
and neoplastic properties of additional
natural and synthetic fibers.
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